Advertisement

Reactions Weekly

, Volume 1673, Issue 1, pp 334–334 | Cite as

Ruxolitinib

Various toxicites: 5 case reports
Case report
  • 23 Downloads

Reference

  1. Blechman AB, et al. Aggressive skin cancers occurring in patients treated with the Janus Kinase inhibitor ruxolitinib. Journal of Drugs in Dermatology 16: 508-511, No. 5, May 2017. Available from: URL: https://www.ncbi.nlm.nih.gov/pubmed/28628689 - USAPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations